FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns a method of inhibiting the total activity of the basic (alkaline) phospholipase A2 of mononuclear cells, involving administering to the animal a drug, where such agent is represented by a composition containing bis(μ-tartrate)di(μ-hydroxo)germanate (IV) of triethanolammonium and a pharmaceutically acceptable aqueous carrier which is administered intramuscularly in an animal in dose of 10 mg of the active substance/kg daily for 2 months.
EFFECT: invention provides inhibition of total activity of basic (alkaline) phospholipase A2 of mononuclear cells.
4 cl, 1 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF BIS(Μ-TARTRATO)DI(Μ-HYDROXO)GERMANATE (IV) TRIETHANOLAMMONIUM FOR INHIBITING TOTAL ACTIVITY OF BASIC (ALKALINE) PHOSPHOLIPASE A2 OF MONONUCLEAR CELLS | 2020 |
|
RU2733166C1 |
| USE OF 1-(HERMATRANE-1-YL)-1-OXYETHYLAMINE FOR INHIBITING TOTAL ACTIVITY OF BASIC (ALKALINE) PHOSPHOLIPASE A2 OF MONONUCLEAR CELLS | 2020 |
|
RU2732883C1 |
| METHOD FOR SUPPRESSING TOTAL ACTIVITY OF BASIC (ALKALINE) PHOSPHOLIPASE A2 OF MONONUCLEAR CELLS USING 1-(HERMATRANE-1-YL)-1-OXYETHYLAMINE | 2020 |
|
RU2732881C1 |
| APPLICATION OF PROTATRAN 4-CHLORO-2-METHYLPHENOXYACETATE FOR EXHAUSTING OF MONONUCLEAR CELLS BASIC (ALKALINE) PHOSPHOLIPASE a2 TOTAL ACTIVITY | 2016 |
|
RU2619860C1 |
| BIS(µ-TARTRATO)DI(µ-HYDROXO)GERMANATE(IV) TRIETHANOLAMMONIUM INCREASING THE STATIC AND DYNAMIC PERFORMANCE | 2016 |
|
RU2661616C2 |
| USING COMPLEX OF TRIS-(2-HYDROXYETHYL)AMINE AND ZINC BIS-(2-METHYLPHENOXYACETATE) (CINKATRAN) AS AGENT SUPPRESSING TOTAL ACTIVITY OF BASIC (ALKALINE) MONONUCLEAR PHOSPHOLIPASE A2 | 2014 |
|
RU2546537C1 |
| AGENT MODULATING BIOENERGY OF MITOCHONDRIA OF LIVER CELLS OF ANIMAL ORIGIN | 2020 |
|
RU2744009C1 |
| 1-HYDROXYGERMATRANE USAGE FOR INHIBITING THE DEVELOPMENT OF ATHEROSCLEROSIS IN THE EXPERIMENT | 2020 |
|
RU2742972C1 |
| USING COMPLEX OF TRIS-(2-HYDROXYETHYL)AMINE AND BIS-(2-METHYLPHENOXY-ACETATE) ZINC (ZINCATRAN) FOR REDUCING TOTAL ACTIVITY OF ACIDIC PHOSPHOLIPASE A1 | 2014 |
|
RU2545888C1 |
| USE OF 1-(GERMATRAN-1-YL)-1-HYDROXYETHYLAMINE FOR INHIBITING THE DEVELOPMENT OF ATHEROSCLEROSIS IN THE EXPERIMENT | 2020 |
|
RU2746321C1 |
